2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow GED0301: new trials by email Literature Review of GED0301 trials Research Report on GED0301
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease GED-0301, Placebo - Crohn's Disease | Phase 3 | Terminated | Celgene | 310 | 2016-07-25 | 2019-01-29 |
| Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease GED-0301, Placebo - Crohn Disease | Phase 3 | Terminated | Celgene | 701 | 2015-12-08 | 2019-08-28 |
Crohn Disease (2) · Irritable Bowel Syndrome (1)
Celgene (2)
Australia (2) · Austria (2) · Belgium (2) · Bulgaria (2) · Canada (2) · Croatia (2) · Czechia (2) · Denmark (2) · France (2) · Germany (2) · Greece (2) · Hungary (2) · Israel (2) · Italy (2) · Latvia (2)